BioCatalystWatch
ADMAWorkspace / ADMA / OverviewCompany library
ADMA BIOLOGICS, INC. logo

ADMA BIOLOGICS, INC.

ADMA BIOLOGICS, INC. (ADMA)

Website

Price
Market cap
Next catalystMid-November 2026ASCENIV · Data readoutCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

SG-001

S. pneumoniae

PreINDP1P2P3FilingApproved
Upcoming / outlook

ASCENIV

RSV

Approved

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

ASCENIV

RSV

Approved

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

SG-001

S. pneumoniae

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

ASCENIV

RSV

ASCENIV

RSV

Approved / commercial

Hepatitis B virus

Approved

PreINDP1P2P3FilingApproved

History / paused

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

ADMA PR & News

ADMA SEC archive